Cargando…

Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort

BACKGROUND: Clinically significant drug-drug interactions (CSDIs) involving antiretrovirals are frequent and under-recognized in developed countries, but data are lacking for developing countries. METHODOLOGY AND PRINCIPAL FINDINGS: To investigate the prevalence of CSDIs between antiretrovirals and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kigen, Gabriel, Kimaiyo, Sylvester, Nyandiko, Winstone, Faragher, Brian, Sang, Edwin, Jakait, Beatrice, Owen, Andrew, Back, David, Gibbons, Sara, Seden, Kay, Khoo, Saye H.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044141/ https://www.ncbi.nlm.nih.gov/pubmed/21373194 http://dx.doi.org/10.1371/journal.pone.0016800

Ejemplares similares

Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection
por: Seden, Kay, et al.
Publicado: (2017)

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
por: Hodge, Daryl, et al.
Publicado: (2021)

Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications
por: Stader, Felix, et al.
Publicado: (2018)

Pharmacokinetics-based adherence measures for antiretroviral therapy in HIV-infected Kenyan children
por: Tu, Wanzhu, et al.
Publicado: (2017)

Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers
por: Kigen, Gabriel, et al.
Publicado: (2017)

Evaluating pharmacist involvement in HIV outpatient clinics: can medication histories, drug interaction checks and adherence assessments add benefit?
por: Seden, K, et al.
Publicado: (2010)

COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions
por: Back, David, et al.
Publicado: (2020)

Added Value of Next Generation Sequencing in Characterizing the Evolution of HIV-1 Drug Resistance in Kenyan Youth
por: Novitsky, Vlad, et al.
Publicado: (2023)

Use of a physiologically-based pharmacokinetic model to simulate artemether dose adjustment for overcoming the drug-drug interaction with efavirenz
por: Siccardi, Marco, et al.
Publicado: (2013)

Real-Life Feasibility of HIV Drug Resistance Testing Using Dried Filter Analytes in Kenyan Children and Adolescents Living with HIV
por: Manne, Akarsh, et al.
Publicado: (2022)

High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily
por: Seden, Kay, et al.
Publicado: (2018)

Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis
por: Duwal, Sulav, et al.
Publicado: (2019)

Prevalence and type of drug–drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda
por: Seden, K., et al.
Publicado: (2015)

HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users
por: Budambula, Valentine, et al.
Publicado: (2015)

A Review of the Ingredients Contained in Over the Counter (OTC) Cough Syrup Formulations in Kenya. Are They Harmful to Infants?
por: Kigen, Gabriel, et al.
Publicado: (2015)

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
por: Marzolini, Catia, et al.
Publicado: (2022)

Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs
por: Ndakala, Frank Ndaks, et al.
Publicado: (2016)

Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies
por: Waitt, Catriona John, et al.
Publicado: (2015)

Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
por: Fairlie, Lee, et al.
Publicado: (2019)

Factors contributing to antiretroviral drug adherence among adults living with HIV or AIDS in a Kenyan rural community
por: Kioko, Mary T., et al.
Publicado: (2017)

Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug Resistance
por: Novitsky, V., et al.
Publicado: (2022)

Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling
por: Grañana-Castillo, Sandra, et al.
Publicado: (2022)

Enhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticles
por: Kigen, Gabriel, et al.
Publicado: (2018)

Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals
por: Byakika-Kibwika, Pauline, et al.
Publicado: (2011)

An in vitro evaluation of drugs used in the Kenyan ART program
por: Muriuki, Joseph, et al.
Publicado: (2016)

885. HIV-1 Treatment Failure and Extensive Drug Resistance in Perinatally Infected Children Failing First-Line Antiretroviral Therapy in Western Kenya
por: Nyandiko, Winstone, et al.
Publicado: (2019)

HIV-Related Knowledge, Attitudes, Behaviors and Experiences of Kenyan Adolescents Living with HIV Revealed in WhatsApp Group Chats
por: Chory, Ashley, et al.
Publicado: (2021)

Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?
por: Vitoria, Marco, et al.
Publicado: (2016)

Validation of a Short Adherence Questionnaire for Children Living with HIV on Antiretroviral Therapy in Kenya
por: Vreeman, Rachel Christine, et al.
Publicado: (2018)

Monitoring health systems readiness and inpatient malaria case-management at Kenyan county hospitals
por: Zurovac, Dejan, et al.
Publicado: (2018)

Nanodelivery of antiretroviral drugs to nervous tissues
por: Lawal, Sodiq Kolawole, et al.
Publicado: (2022)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015)

An Individual Participant Data Population Pharmacokinetic Meta-analysis of Drug-Drug Interactions between Lumefantrine and Commonly Used Antiretroviral Treatment
por: Francis, Jose, et al.
Publicado: (2020)

Safety perspectives on presently considered drugs for the treatment of COVID‐19
por: Penman, Sophie L., et al.
Publicado: (2020)

Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector
por: Amin, Abdinasir A, et al.
Publicado: (2005)

Antiretroviral drug–drug interactions: A comparison of online drug interaction databases
por: Drwiega, Emily N., et al.
Publicado: (2022)

Drug–drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs
por: Petrykiv, S., et al.
Publicado: (2022)

Antiretroviral Drug Interactions: Overview of Interactions Involving New and Investigational Agents and the Role of Therapeutic Drug Monitoring for Management
por: Rathbun, R. Chris, et al.
Publicado: (2011)

Measuring adherence to antiretroviral therapy in children and adolescents in western Kenya
por: Vreeman, Rachel C, et al.
Publicado: (2014)

Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent
por: Rosen, Elias P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhmp267f54t1lmsd9idciik28e